Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis:ex vivo permeation and pharmacokinetic studies | Salwa Salah

Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis:ex vivo permeation and pharmacokinetic studies

Citation:: Salah, S., A. A.mahmoud, and A. O.kamel, "Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis:ex vivo permeation and pharmacokinetic studies", Drug delivery, vol. 24(1), issue 1071-7544, pp. 846-856, 2017.